Pedro Miguel Salcedo-Gómez, M.D.; Ph.D. - Physician, HIV specialist

Pedro Miguel Salcedo-Gómez

M.D.; Ph.D.

Physician, HIV specialist

Bogotá D.C., Cundinamarca | Colombia

Main Specialties: Infectious Disease

ORCID logohttps://orcid.org/0000-0001-6018-4815

Pedro Miguel Salcedo-Gómez, M.D.; Ph.D. - Physician, HIV specialist

Pedro Miguel Salcedo-Gómez

M.D.; Ph.D.

Introduction

Specialties:

Research Interests:

Publications

7Publications

123Reads

1Profile Views

A novel tricyclic ligand-containing nonpeptidic HIV-1 protease inhibitor, GRL-0739, effectively inhibits the replication of multidrug-resistant HIV-1 variants and has a desirable central nervous system penetration property in vitro.

Antimicrob Agents Chemother 2015 May 17;59(5):2625-35. Epub 2015 Feb 17.

Departments of Infectious Diseases and Hematology, Kumamoto University School of Medicine, Kumamoto, Japan Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/AAC.04757-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394833PMC
May 2015
6 Reads
4.476 Impact Factor